Home › Research › Prevention and risk
The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC
Giulia Peduzzi, Lívia Archibugi, Riccardo Farinella, Ruggero Ponz de Leon Pisani, Ľudmila Vodičková, Pavel Vodička, Bledar Kraja, Juan Sáinz et al.. Seminars in Cancer Biology, 2025-05-12
Topic: Brain proteins, microglia and lab models
Plain-language summary
Pancreatic cancer (PC), particularly pancreatic ductal adenocarcinoma (PDAC), is a significant global health issue with high mortality rates. PDAC, though only 3 % of cancer diagnoses, causes 7 % of cancer deaths due to its severity and asymptomatic early stages. Risk factors include lifestyle choices, environmental exposures, and genetic predispositions. Conditions like new-onset type 2 diabetes and chronic pancreatitis also contribute significantly. Modifiable risk factors include smoking, alcohol consumption, non-alcoholic fatty pancreatic disease (NAFPD), and obesity. Smoking and heavy alcohol consumption increase PC risk, while NAFPD and obesity, particularly central adiposity, contribute through chronic inflammation and insulin resistance. Refined sugar and sugar-sweetened beverages (SSBs) are also linked to increased PC risk, especially among younger individuals. Hormonal treatments and medications like statins, aspirin, and metformin have mixed results on PC risk, with some showing protective effects. The gut microbiome influences PC through the gut-pancreas axis, with disruptions leading to inflammation and carcinogenesis. Exposure to toxic substances, including heavy metals and chemicals, is associated with increased PC risk. Glycome changes, such as abnormal glycosylation patterns, are significant in PDAC development and offer potential for early diagnosis. Interactions between environmental and genetic factors are crucial in PDAC susceptibility. Genome-wide association studies (GWAS) have identified several single nucleotide polymorphisms (SNPs) linked to PDAC, but gene-environment interactions remain largely unexplored. Future research should focus on polygenic risk scores (PRS) and large-scale studies to better understand these interactions and their impact on PDAC risk.
What this study adds
Evidence grade: Low
This review is about the exposome and pancreatic cancer, including lifestyle and environmental risk factors for pancreatic ductal adenocarcinoma. It does not address Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Peduzzi, G., Archibugi, L., Farinella, R., Pisani, R. P. d. L., Vodičková, Ľ., Vodička, P., et al. (2025). The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2025.05.004
Vancouver
Peduzzi G, Archibugi L, Farinella R, Pisani RPdL, Vodičková Ľ, Vodička P, et al. The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC. Seminars in Cancer Biology. 2025. doi:10.1016/j.semcancer.2025.05.004. PMID: 40368260.
BibTeX
@article{peduzzi2025-40368260,
author = {Peduzzi, Giulia and Archibugi, Lívia and Farinella, Riccardo and Pisani, Ruggero Ponz de Leon and Vodičková, Ľudmila and Vodička, Pavel and Kraja, Bledar and Sáinz, Juan and others},
title = {{The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC}},
journal = {Seminars in Cancer Biology},
year = {2025},
doi = {10.1016/j.semcancer.2025.05.004},
pmid = {40368260},
url = {https://doi.org/10.1016/j.semcancer.2025.05.004}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Pancreatic cancer (PC), particularly pancreatic ductal adenocarcinoma (PDAC), is a significant global health issue with high mortality rates.
- Conditions like new-onset type 2 diabetes and chronic pancreatitis also contribute significantly.
- Hormonal treatments and medications like statins, aspirin, and metformin have mixed results on PC risk, with some showing protective effects.
- Exposure to toxic substances, including heavy metals and chemicals, is associated with increased PC risk.
- Glycome changes, such as abnormal glycosylation patterns, are significant in PDAC development and offer potential for early diagnosis.
Why it matters
This review is about the exposome and pancreatic cancer, including lifestyle and environmental risk factors for pancreatic ductal adenocarcinoma. It does not address Alzheimer's disease.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 46/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Seminars in Cancer Biology) |
| Journal's citation record | 2 / 4 | Seminars in Cancer Biology: journal h-index 227 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 32 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 10.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 11.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 32 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Cosmeri Rizzato: h-index 30 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Pisa: institution h-index 907 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 14 institution(s) in 8 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40368260) |
| Free to read | 2 / 2 | Free to read |
| Total | 46 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.semcancer.2025.05.004
- PubMed: 40368260
- Original source →
- Free full text: Seminars in Cancer Biology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Prevention and risk from nearby years
Also in Prevention and risk
269 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.